Teva Pharmaceuticals (NYSE:TEVA) employee Robert Huellemeier launched a proposed class action suit against the generic drugmaker this week, alleging that the company hid that it was under investigation for price fixing and bribery.
Huellemeier, who bought TEVA shares through a company program, accused the company of leaving out any mention of multiple investigations in regulatory notes with the SEC.
Get the full story at our sister site, Drug Delivery Business News.
The post Employee alleges Teva hid DOJ antitrust probe in lawsuit appeared first on MassDevice.